| Symbol | IPHA |
|---|---|
| Name | INNATE PHARMA SA |
| Sector | UNDEFINED |
| Region | UNDEFINED |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 117 AVENUE DE LUMINY, MARSEILLE, None 13009 |
| Telephone | 33430303030 |
| Fax | — |
| — | |
| Website | — |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001598599 |
| Description | None |
Sobi enters strategic partnership with Innate Pharma to license lacutamab in T-cell lymphoma
Read moreInnate Pharma - Innate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
Read moreInnate Pharma to Advance Lacutamab Towards Phase 3 Following Partnership With Sobi and Appoints New Chief Medical Officer
Read moreInnate Pharma fait progresser lacutamab vers la phase 3 à la suite de son partenariat avec Sobi et nomme un nouveau directeur médical
Read moreInnate Pharma - Innate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
Read moreInnate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
Read moreInnate Pharma conclut un partenariat stratégique avec Sobi pour lacutamab dans les lymphomes T
Read moreInnate Pharma Enters Strategic Partnership With Sobi to License Lacutamab in T-cell Lymphoma
Read moreInnate Pharma - Innate Pharma to Participate in a Bladder Cancer Panel at the BTIG Virtual Biotechnology Conference
Read more